The oral tablet formulation, branded as Wegovy semaglutide tablets, was approved by the US Food and Drug Administration (FDA) in December 2025 following the Phase 3 OASIS 4 clinical trial
Over a mean follow-up of 3.9 years, the use of glucagon-like peptide 1 (GLP1) receptor agonists was not associated with an increased risk of thyroid cancer, according to a study published in The BMJ
Muscles help stabilize the knees, hips, shoulders, back, and other joints
Enhanced Fat Metabolism: Supports the body's ability to convert fat into energy
Always put the pen cap back on when youre not using the pen to protect it from heat and direct sunlight
This is the medication working as intended, signaling your brain that you're satisfied with less food